RAFGX
Price
$47.02
Change
+$0.80 (+1.73%)
Updated
Aug 22 closing price
Net Assets
94.9B
RGACX
Price
$82.18
Change
+$1.56 (+1.94%)
Updated
Aug 22 closing price
Net Assets
328.96B
Interact to see
Advertisement

RAFGX vs RGACX

Header iconRAFGX vs RGACX Comparison
Open Charts RAFGX vs RGACXBanner chart's image
American Funds AMCAP R6
Price$47.02
Change+$0.80 (+1.73%)
VolumeN/A
Net Assets94.9B
American Funds Growth Fund of Amer R3
Price$82.18
Change+$1.56 (+1.94%)
VolumeN/A
Net Assets328.96B
RAFGX vs RGACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RAFGX vs. RGACX commentary
Aug 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RAFGX is a Buy and RGACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 329B vs. RAFGX (94.9B). RAFGX pays higher dividends than RGACX: RAFGX (0.56) vs RGACX (0.07). RAFGX was incepted earlier than RGACX: RAFGX (16 years) vs RGACX (23 years). RGACX (0.94) is less costly to investors than RAFGX (0.33). RAFGX is a more actively managed with annual turnover of: 36.00 vs. RGACX (25.00). RAFGX (250) and RGACX (250) have matching initial minimum investment requirements. RGACX annual gain was more profitable for investors over the last year : 14.04 vs. RAFGX (7.39). RGACX return over 5 years is better than : 39.56 vs. RAFGX (32.75).
RAFGXRGACXRAFGX / RGACX
Total Expense Ratio0.330.9435%
Annual Report Gross Expense Ratio0.330.9435%
Fund Existence16 years23 years-
Gain YTD7.45014.15553%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets94.9B329B29%
Annual Yield % from dividends0.560.07768%
Returns for 1 year7.3914.0453%
Returns for 3 years44.4248.4392%
Returns for 5 years32.7539.5683%
Returns for 10 years86.12104.2183%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EUDA2.600.17
+6.91%
EUDA Health Holdings Limited
YRD6.160.12
+1.99%
Yiren Digital Ltd
OGN9.430.15
+1.62%
Organon & Co
FMS25.600.34
+1.35%
Fresenius Medical Care AG
PMCB0.970.01
+1.04%
PharmaCyte Biotech